CurrentCapital BluecrossPolicy MP 3.016

Drug Infusion Site of Service

Defines medical necessity criteria for the site of care for listed infused injectable medications and governs decisions about infusion in hospital outpatient settings versus less intensive settings (home, outpatient infusion center, physician office) for Capital Blue Cross members.

Policy Summary

PayerCapital Bluecross

PolicyDrug Infusion Site of Service

Policy CodePolicy MP 3.016

Change TypeNo material changes

Effective DateApr 1, 2025

Next Review Date

Key ActionA one-time 30-day approval is granted for infusions initiated in a hospital outpatient setting to permit transition to a less intensive site when coverage criteria are met.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

~80+listed infused medications covered by this site-of-service policy

30 daysone-time hospital outpatient approval period for transition

20 milesdistance threshold for non-hospital affiliated outpatient infusion center access

J-codes listprocedure/billing codes referenced in coding section

Coverage Criteria — Hospital Outpatient Infusion

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Hospital outpatient medical necessity

Infusion in a hospital outpatient setting or hospital-affiliated infusion suite is considered medically necessary when ANY one of the following is met:

Hospital outpatient medically necessary criteria: The prescribed medication has a site‑of‑care restriction per the FDA‑approved label; OR clinical documentation of a significant comorbidity (e.g., cardiopulmonary disorder) or concerns regarding fluid overload that preclude treatment at a less intensive site of care; OR clinical documentation of a severe or potentially life‑threatening adverse event during or following a prior infusion that cannot be managed with pre‑medication in the home or office setting; OR clinical documentation of unstable vascular access; OR the patient’s current condition requires monitoring that cannot be provided in a less intensive site of care; OR clinical documentation of physical or cognitive impairments such that home infusion would present an unnecessary health risk; OR the patient is concurrently being treated with another medication that must be administered in a hospital setting; OR reinitiating therapy after being off therapy for at least six months; OR initiating a new therapyany of the listed conditions

Presence of any single listed condition supports medical necessity; do not flatten nested logic.

Hospital-to-less-intensive transition

If infusion is initiated in the hospital outpatient setting:

One-time transition approval: A one-time 30‑day approval is allowed to facilitate transition to a less intensive site of care (home infusion, non‑hospital affiliated outpatient infusion center, or physician office) when medication coverage criteria are met.30 days

Transition should be to an appropriate less intensive site when feasible; provider must arrange transition within the approval period.

Not medically necessary

Hospital outpatient infusion is considered not medically necessary when ALL of the following are true:

Not medically necessary: No clinical documentation supports any of the hospital outpatient medical necessity criteria above (e.g., no FDA site‑of‑care restriction, no significant comorbidity, no unstable vascular access, no requirement for monitoring unavailable in less intensive sites, etc.) AND an appropriate less intensive site of care is available (including a non‑hospital affiliated outpatient infusion center within an acceptable distance or home infusion eligibility).N/A

Policy indicates infusion is not medically necessary when the listed criteria are not met and alternatives are available (see 20‑mile distance threshold and home infusion eligibility).

The existence of this medical policy does not guarantee that a specific service is a covered benefit under a member’s health benefit plan. Benefit determinations are based on the member’s applicable plan language, and medical policies do not by themselves describe plan benefits. Providers and members should consult the member’s health benefit plan or contact Capital Blue Cross for benefit coverage information prior to scheduling services.

Infusion in a hospital outpatient setting or hospital‑affiliated infusion suite is considered not medically necessary when documentation does not demonstrate ANY one of the clinical justifications listed in this policy (for example: FDA site‑of‑care restriction, significant comorbidity or fluid‑overload concerns, prior severe infusion reaction not manageable in home/office, unstable vascular access, need for monitoring unavailable in less intensive sites, physical or cognitive impairments, concurrent hospital‑only medication, reinitiation after ≥6 months off therapy, or initiation of new therapy). When these criteria are not met and a less intensive site of care is available, hospital outpatient infusion is not medically necessary.

Provider Actions, Approvals, and Documentation

Step Therapy

Site-of-care escalation/step — Consider less intensive sites of care

Policy requires consideration of alternative less intensive sites of care before continued hospital outpatient infusion. If an infusion is initiated in a hospital outpatient setting, the provider must plan transition to a less intensive site of care (e.g., home infusion, non-hospital outpatient infusion center such as an ambulatory infusion center or physician office) whenever clinically appropriate.

Consider home infusion when home is within the provider/agency service area and suitable for care.
Consider non-hospital affiliated outpatient infusion centers (ambulatory infusion center or physician office) when available within a reasonable distance to the member's home.

Prior Authorization

One-time 30-day hospital outpatient approval

A one-time 30-day approval is granted for infusions initiated in a hospital outpatient setting to permit transition to a less intensive site of care. This limited approval is intended to allow arranging home infusion services or transfer to a non-hospital affiliated outpatient infusion center when medically appropriate.

One-time 30-day approval applies only to hospital outpatient infusions initiated in that setting.
During the 30-day period, the provider must document efforts to transition the member to a less intensive site of care.

Documentation Required

Required clinical documentation

Clinical documentation must support the justification for hospital outpatient infusion. Examples of acceptable documentation include FDA label site-of-care restrictions, documentation of significant comorbidity or monitoring needs, unstable vascular access, severe prior infusion adverse events that cannot be managed outside the hospital, or evidence that home infusion services are not available or appropriate.

Document the specific clinical reason for hospital outpatient administration.
Include notes on attempts to arrange home infusion or identify a non-hospital outpatient infusion center within a reasonable distance.

Denial Risk

Not medically necessary when criteria not met

Infusion in a hospital outpatient setting or hospital-affiliated infusion suite is considered not medically necessary when the criteria for hospital outpatient administration are not met, or when a less intensive site of care is available and appropriate but was not pursued. Denials may result if documentation does not justify continued hospital outpatient care or show attempts to transition to a less intensive site.

If criteria for hospital outpatient infusion are not met, the service is not medically necessary.
Failure to document site-of-care considerations or transition efforts increases risk of claim denial.

Note

30-day transition limitation

Hospital outpatient infusions initiated in that setting are subject to a one-time 30-day approval to allow transition to a less intensive site of care. Providers should plan and document transition actions within that 30-day period.

The 30-day transition limitation is a one-time allowance per course of therapy initiated in the hospital outpatient setting.
Continuation beyond 30 days requires meeting hospital outpatient administration criteria with supporting documentation.

Definitions and Expectations

inv-14: Less intensive site of care — Home infusion, non-hospital affiliated outpatient infusion center (ambulatory infusion center or physician office) where the medication c...

Less intensive site of care (definition)Home infusion or non-hospital affiliated outpatient infusion (e.g., ambulatory infusion center or physician office) where the medication can be administered and monitoring needs can be met.

Hospital outpatient setting expectationsFacility expected to have immediate access to emergency resuscitation equipment and personnel (ACLS), emergency services, and inpatient admission or intensive care if necessary.

PurposePreferred site is a less intensive site of care when medication coverage criteria are met; hospital outpatient is reserved when specified clinical necessity criteria are present or for a one-time 30-day transition.

inv-15: Hospital outpatient setting expectations — Facility is expected to have immediate access to emergency resuscitation equipment and personnel (ACLS), emergency services, inpatient ad...

Emergency readinessImmediate access to emergency resuscitation equipment and personnel (Advanced Cardiac Life Support protocol)

Support servicesAccess to emergency services

Escalation capabilityAbility to arrange inpatient admission or intensive care if necessary

J0897
J1299
J1302
J1303
J1305
J1306
J1322
J1458
J1459
J1551

OpenPayer

Drug Infusion Site of Service

Coverage Criteria — Hospital Outpatient Infusion

Procedure and Billing Codes

Provider Actions, Approvals, and Documentation

Preferred and Alternate Sites of Care

Definitions and Expectations

Background and Rationale